Recent research by Sureshbabu et al. suggests that TGFβ-mediated apoptosis, inflammation, reduced alveolarization and impaired angiogenesis in a BPD mouse model is via the type II TGFβ receptor (TGFβR2) (62). This evidence concerns the gene TGFB1 and bronchopulmonary dysplasia.